Artificial intelligence in oncology: European REVERT
REVERT, is a EU Horizon 2020 funded project aiming to apply artificial intelligence to develop predictive algorithms to be used in clinical treatment of patients with advanced colorectal cancer.
Personalised medicine model for the treatment of advanced colorectal cancer.
The EU-funded REVERT project will address at systems level the pathophysiology of advanced colorectal cancer in patients responding well or poorly to therapies, with the goal to design an optimal strategy for therapeutic interventions depending on patients' features. This goal will be achieved using a large number of standardised biobank samples and clinical databases from several clinical European centres, including known and new potential prognostic biomarkers. Following the AI-based data analysis, results will be evaluated for the REVERT-DataBase impact on survival and quality of life in prospective clinical trials. The project will also generate a broad network among industrial and academic partners focused on the development of personalised medicine.